Catalent Pharma Solutions Appoints New Vice President of Scientific Affairs
Somerset, NJ – May 4, 2011 — Catalent Pharma Solutions, Inc. announced the appointment of Rao Tatapudy, R. Ph., Ph.D. as Vice President of Scientific Affairs, Innovation & Growth. Dr. Tatapudy will be responsible for strategic programs in R&D and technology platforms with a focus on innovation and growth of current technology platforms and advances in bioavailability enhancement, taste masking, modified release and particle engineering. He will be located at Catalent’s corporate headquarters in Somerset, NJ.
Dr. Tatapudy joins Catalent from Pfizer, where he was New Product Leader and Director of New Product and Process Development with responsibility in Global Manufacturing services. Prior to Pfizer, he spent 21 years with Wyeth Pharmaceuticals in various departments including Brand, Toxicology, Generic, Life Cycle, Technical Operations and Product Supply (TO&PS) in various roles, including Project Management and Line Management. Prior to Wyeth he worked at Chelsea Labs (now Watson), Tata Pharma and GD Searle.
Dr. Tatapudy holds a Ph.D. and M.S. in Industrial Pharmacy from St. John’s University in Queens, NY and is a registered Pharmacist in the state of New York.
Kurt Nielsen, Catalent’s Senior Vice President, Innovation & Growth, said, “We are pleased to welcome Rao to Catalent. He brings with him extensive knowledge of life cycle management, brand and generic products, project management, new product and process development which will help him drive sustainable long term growth for Catalent.”
From drug and biologic development services to delivery technologies to supply solutions, Catalent Pharma Solutions has the deepest expertise, the broadest offerings and the most unique technologies in the industry. With over 75 years of experience, Catalent helps customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging solutions. Catalent employs approximately 8,000 people at 24 facilities worldwide and in fiscal year 2010 generated more than $1.7 billion in annual revenue. Catalent is headquartered in Somerset, NJ.